<SEC-DOCUMENT>0001628280-24-049889.txt : 20241204
<SEC-HEADER>0001628280-24-049889.hdr.sgml : 20241204
<ACCEPTANCE-DATETIME>20241204150051
ACCESSION NUMBER:		0001628280-24-049889
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20241204
FILED AS OF DATE:		20241204
DATE AS OF CHANGE:		20241204

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CYBIN INC.
		CENTRAL INDEX KEY:			0001833141
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40673
		FILM NUMBER:		241525938

	BUSINESS ADDRESS:	
		STREET 1:		100 KING STREET WEST
		STREET 2:		SUITE 5600
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5X 1C9
		BUSINESS PHONE:		(908) 764-8385

	MAIL ADDRESS:	
		STREET 1:		100 KING STREET WEST
		STREET 2:		SUITE 5600
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5X 1C9
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>cybininc-form6xk12x04x2024.htm
<DESCRIPTION>6-K
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="ic2086c518bc74c6ab00917338748edfa_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="-sec-extract:summary;margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">UNITED STATES<br>SECURITIES AND EXCHANGE COMMISSION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Washington, D.C. 20549</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><br><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Form 6-K</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><br><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16<br>UNDER THE SECURITIES EXCHANGE ACT OF 1934</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the month of December, 2024.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Commission File Number&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">001-40673</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Cybin Inc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(Exact Name of Registrant as Specified in Charter)<br><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">100 King Street West, Suite 5600, Toronto, Ontario, M5X 1C9 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(Address of principal executive offices) </font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Form 20-F  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:115%">&#9633;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">  Form 40-F &#8864;</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">SIGNATURE</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.<br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:5.048%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.696%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.851%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.507%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">CYBIN INC.</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(Registrant)</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">December 4, 2024</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">&#47;s&#47; Doug Drysdale&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Name&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Doug Drysdale</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">EXHIBIT INDEX</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">99.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a href="a12-04x2024watertowerfires.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">News Release dated December 4, 2024</a></font></div></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a12-04x2024watertowerfires.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i93c9fb5aa3a9443b990b04d8f6be6e0c_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:133%"> </font></div><div style="text-align:center"><img alt="image_0.jpg" src="image_0.jpg" style="height:120px;margin-bottom:5pt;vertical-align:text-bottom;width:206px"></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:133%"> Cybin to Participate in Water Tower Research Fireside Chat on December 11, 2024</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%"><br></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">TORONTO, CANADA </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8211; December 4, 2024 &#8211; </font><font style="color:#0563c1;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Cybin Inc.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> (NYSE American&#58;CYBN) (Cboe CA&#58;CYBN) (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Cybin</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8221; or the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8221;), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, is pleased to announce that Doug Drysdale, Cybin&#8217;s Chief Executive Officer, and Amir Inamdar, MBBS, DNB (Psych), FFPM, Cybin&#8217;s Chief Medical Officer, will participate in the Water Tower Research Fireside Chat Series taking place on Wednesday, December 11, 2024, at 11&#58;00 a.m. ET. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">The fireside chat will be hosted by Robert Sassoon, Senior Research Analyst at Water Tower Research. Covered topics will include&#58; </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:14.15pt">CYB003&#8217;s 12-month efficacy data from its Phase II study for the treatment of major depressive disorder.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:14.15pt">The initiation of the Cybin&#8217;s Phase III PARADIGM&#8482; program, its design, enrollment process, and milestone targets.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">To listen to the event, please </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">click here</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> to register for the webcast. The archived webcast will also be available on the Company&#8217;s investor relations website on the </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Events &#38; Presentations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> page.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">About Cybin</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Cybin is a late-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options to address the large unmet need for people who suffer from mental health conditions.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">With industry leading proof-of-concept data, Cybin is working to change the mental health treatment landscape through the introduction of intermittent treatments that provide long lasting results. The Company is currently developing CYB003, a proprietary deuterated psilocin analog, in Phase 3 studies for the adjunctive treatment of major depressive disorder and CYB004, a proprietary deuterated N, N-dimethyltryptamine molecule in a Phase 2 study for generalized anxiety disorder. The Company also has a research pipeline of investigational, 5-HT-receptor focused compounds.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom, the Netherlands and Ireland. For Company updates and to learn more about Cybin, visit www.cybin.com or follow the team on X, LinkedIn, YouTube and Instagram.</font><font style="font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Investor &#38; Media Contact&#58;&#160;</font></div><div style="padding-left:0.05pt;padding-right:5.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Gabriel Fahel</font></div><div style="padding-left:0.05pt;padding-right:5.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Chief Legal Officer</font></div><div style="padding-left:0.05pt;padding-right:5.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Cybin Inc.</font></div><div style="padding-left:0.05pt;padding-right:5.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">1-866-292-4601</font></div><div style="padding-left:0.05pt;padding-right:5.75pt;text-align:justify"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">irteam&#64;cybin.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> &#8211; or &#8211; </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">media&#64;cybin.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> </font></div><div style="padding-left:0.05pt;padding-right:5.75pt;text-align:justify"><font><br></font></div><div style="padding-left:0.05pt;padding-right:5.75pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_0.jpg
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MJ=FF'[^6 4Y!$M6S2.(*F2Q!IG<O0LZP'1[XVJ;Y:!_]N Y+EB8G;$K6CTV
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M@$. SIYBF_S;$.BG'/-K9'G$F$)HAH1Y$W!L[$%4<1[R 72_<MRAR!.KMN[
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M*LZ\ MP # LU* <]D%W@.P%KT9HPOP+^A_Q91B %,V(ET$T58]WD^/Y%D48
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M+V&Z]AY+P_>1 *-G8\+OFGT!22ZA6T[UPV&30 TSD%)R6C>EPY7B0+JEF G
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HR)) 9V &\ QP'C QVNB,,::*_P,XN9"3FUCC]     !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
